Navigation Links
H. Kim Lyerly appointed to the National Cancer Advisory Board

H. Kim Lyerly, M.D., director of the Duke Comprehensive Cancer Center, has been appointed by President Bush to the National Cancer Advisory Board.

Lyerly was one of eight appointees named to the board on June 12, 2008.

The National Cancer Advisory Board is an advisory committee of the U.S. National Cancer Institute (NCI). The role of the board is to advise the secretary of the Department of Health and Human Services and the director of the NCI on issues that relate to the activities of the Institute, including reviewing and recommending support grants and cooperative agreements. The board consists of 18 members appointed by the President, and selected from the leading representatives of the health and scientific disciplines.

Lyerly is the George Barth Geller Professor of Cancer Research at the Duke Comprehensive Cancer Center. He is currently the principal investigator of the Cancer Center Core Grant, the Duke Specialized Program in Research Excellence (SPORE) grant in breast cancer, and a program project grant directed toward developing antigen specific immunity in patients with cancer. Lyerly is an internationally recognized expert in cancer therapy and cancer immunotherapy and has published over 150 scientific articles and has edited 10 textbooks on surgery, cancer immunotherapy and novel cancer therapies. He serves on the editorial board of twelve scientific journals.


Contact: Lauren Shaftel Williams
Duke University Medical Center

Page: 1

Related medicine news :

1. AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill
2. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
3. Jeff Bailet, M.D., Appointed to American Medical Associations Advisory Committee
4. David Pizzo Appointed Blue Cross and Blue Shield of Florida Market President - West Florida
5. J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
6. Woodrin Woody Grossman Appointed to MedCaths Board of Directors
7. Dr. Robert CJ Krasner Appointed to as Independent Advisor
8. Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCaths Board of Directors
9. Pioneering Heart Surgeon, Robert E. Michler, M.D., Appointed Chair of Surgery and Surgeon-in-Chief at Einstein and at Montefiore Medical Center
10. Peter Burg Appointed as Co-Chair of the Plaintiffs Steering Committee and the Executive Committee for the Gadolinium-Based Contrast Agents Product Liability Multi-District Litigation
11. Michael D. Farley Appointed Chief Operating Officer of Lupus Foundation of America, Inc.
Post Your Comments:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology: